Natural Product: NPC44063

Natural Product IDNPC44063
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Prednisolone Acetate
IUPAC Name [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
Synonyms Econopred; Flo-Pred; Meticortelone; Omnipred; Pred Forte; Pred Fte; Pred Mild; Prednisolone acetate; Sterane; Ultracortenol
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1152
PubChem CID 5834
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003569] Pregnane steroids
          • [CHEMONTID:0001468] Gluco/mineralocorticoids, progestogins and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LRJOMUJRLNCICJ-JZYPGELDSA-N
Standard InCHI InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1
SMILES CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@H](C[C@]12C)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   402.2 Volume:   411.697
?
Van der Waals volume.
Dense:   0.977 LogP:   1.768
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.084
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.953
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   23.0
TPSA:   100.9
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.702 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.394 Fsp3:   0.696
MCE-18:   75.846
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.567 Fluc inhibitor:   0.043
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.093
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.222 Promiscuous compounds:   0.942

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.049 MDCK Permeability:   -4.731
Pgp-inhibitor:   0.846 Pgp-substrate:   0.015
PAMPA:   0.142
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.917 30% Bioavailability (F30%):   0.946
50% Bioavailability (F50%):   0.974

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   1.0 MRP1:   0.193
Plasma Protein Binding (PPB):   95.401% Volume Distribution (VD):   0.279
Fu: 4.034%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.007
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.962
HLM stability:   0.005
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  7.879 Half-life (T1/2):  1.799

ADMET: Toxicity

hERG Blockers:  0.072 hERG Blockers (10um):  0.153
Human Hepatotoxicity (H-HT):  0.475 Drug-induced Liver Injury (DILI):  0.017
AMES Toxicity:  0.132 Rat Oral Acute Toxicity:  0.432
Maximum Recommended Daily Dose:  0.982 Skin Sensitization:  0.62
Carcinogencity:  0.833 Eye Corrosion:  0.006
Eye Irritation:  0.763 Respiratory Toxicity:  0.687
Drug-induced Neurotoxicity:  0.063 Ototoxicity:  0.306
Hematotoxicity:  0.1 Drug-induced Nephrotoxicity:  0.272
Genotoxicity:  0.939 RPMI-8226 Immunitoxicity:  0.105
A549 Cytotoxicity:  0.002 Hek293 Cytotoxicity:  0.343
BCF:   0.57
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.333
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.013
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.203
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota Roots n.a. n.a. PMID[22916954]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT153 Individual protein Androgen Receptor Homo sapiens Potency n.a. 149.6 nM PubChem BioAssay data set
NPT153 Individual protein Androgen Receptor Homo sapiens Potency n.a. 1068.2 nM PubChem BioAssay data set
NPT153 Individual protein Androgen Receptor Homo sapiens Potency n.a. 237.1 nM PubChem BioAssay data set
NPT211 Individual protein Hypoxia-inducible factor 1 alpha Homo sapiens Potency = 25.1 nM PubChem BioAssay data set
NPT152 Individual protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 51.7 nM PubChem BioAssay data set
NPT1417 Individual protein Transcriptional regulator ERG Homo sapiens Potency n.a. 6309.6 nM PubChem BioAssay data set
NPT152 Individual protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 41.1 nM PubChem BioAssay data set
NPT246 Individual protein Dopamine transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT262 Individual protein Muscarinic acetylcholine receptor M1 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT30 Individual protein Cyclooxygenase-1 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1788 Individual protein Alpha-1a adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT242 Individual protein Dopamine D1 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT295 Individual protein Serotonin transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT263 Individual protein Muscarinic acetylcholine receptor M2 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT218 Individual protein Adenosine A3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1478 Individual protein Vascular endothelial growth factor receptor 2 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT228 Individual protein Norepinephrine transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT222 Individual protein Alpha-2a adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT291 Individual protein Serotonin 2b (5-HT2b) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT244 Individual protein Dopamine D3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT108 Individual protein Estrogen receptor alpha Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT153 Individual protein Androgen Receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT261 Individual protein Monoamine oxidase A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2761 Individual protein Phosphodiesterase 4A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT145 Individual protein Mu opioid receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT204 Individual protein Acetylcholinesterase Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2769 Individual protein Thromboxane A2 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT72 Individual protein Solute carrier organic anion transporter family member 1B3 Homo sapiens Inhibition = 106.69 % PMID[23571415]
NPT987 Individual protein Histamine H3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT73 Individual protein Solute carrier organic anion transporter family member 1B1 Homo sapiens Inhibition = 63.69 % PMID[23571415]
NPT444 Individual protein Ubiquitin carboxyl-terminal hydrolase 1 Homo sapiens Potency n.a. 14125.4 nM PubChem BioAssay data set
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 38.15 % DOI[10.6019/CHEMBL4495564]
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = -61.23 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 0.41 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT98 Individual protein HERG Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT542 Individual protein Progesterone receptor Homo sapiens AC50 = 28273.5 nM PMID[37468498]
NPT8 Individual protein DNA polymerase iota Homo sapiens Potency n.a. 89125.1 nM PubChem BioAssay data set
NPT861 Individual protein Isocitrate dehydrogenase [NADP] cytoplasmic Homo sapiens Potency n.a. 14581.0 nM PubChem BioAssay data set
NPT92 Individual protein Serotonin 1a (5-HT1a) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT5104 Individual protein Phosphodiesterase 3A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT536 Nucleic acid microRNA 21 Homo sapiens Potency = 46.5 nM PubChem BioAssay data set
NPT670 Individual protein Thrombin Homo sapiens AC50 > 30000.0 nM PMID[37468498]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell line HepG2 Homo sapiens Potency n.a. 446.7 nM PubChem BioAssay data set
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Potency n.a. 20786.5 nM PubChem BioAssay data set
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 59.99 % DOI[10.21203/rs.3.rs-23951/v1]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.63 % DOI[10.6019/CHEMBL4495565]
NPT20 Organism Candida albicans Candida albicans Inhibition = 0.73 % DOI[10.6019/CHEMBL4513141]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 12.95 % DOI[10.6019/CHEMBL4513141]
NPT29392 Protein complex Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = 1.81 % DOI[10.6019/CHEMBL4513141]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 16.93 % DOI[10.6019/CHEMBL4513141]
NPT2 Others Unspecified n.a. Potency n.a. 11883.2 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 2389.1 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 237.1 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 169.3 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 33491.5 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 473 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 149.6 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 150.9 nM PubChem BioAssay data set
NPT897 Others Monoclonal antibody (mAb) n.a. IC50 ratio = 12000.0 n.a. PMID[12109909]
NPT2 Others Unspecified n.a. Potency n.a. 115.8 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 326.4 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 25929.0 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. AC50 n.a. 7079.5 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. AC50 n.a. 44668.4 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. AC50 n.a. 28183.8 nM PubChem BioAssay data set
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = 25.62 % DOI[10.6019/CHEMBL4513141]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT605 Organism Homo sapiens Homo sapiens Potency = 1.0 n.a. PMID[6827553]
NPT29 Organism Rattus norvegicus Rattus norvegicus Potency = 3.0 n.a. PMID[6827553]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC44063 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.75 Intermediate Similarity NPC334061
0.5733 Remote Similarity NPC488911
0.5694 Remote Similarity NPC478926
0.5658 Remote Similarity NPC482048
0.5362 Remote Similarity NPC144956
0.5143 Remote Similarity NPC169375
0.5132 Remote Similarity NPC2766

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC44063 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD5697 Phase 4
0.8983 High Similarity NPD6899 Phase 4
0.8361 Intermediate Similarity NPD4729 Approved
0.8226 Intermediate Similarity NPD4730 Phase 4
0.7681 Intermediate Similarity NPD8297 Phase 4
0.75 Intermediate Similarity NPD4696 Phase 4
0.6923 Remote Similarity NPD5739 Phase 4
0.6818 Remote Similarity NPD4632 Approved
0.6456 Remote Similarity NPD7057 Phase 3
0.6456 Remote Similarity NPD7058 Phase 2
0.6386 Remote Similarity NPD7962 Phase 2
0.6375 Remote Similarity NPD7239 Suspended
0.6 Remote Similarity NPD6649 Approved
0.5921 Remote Similarity NPD6650 Phase 4
0.589 Remote Similarity NPD7320 Phase 4
0.5821 Remote Similarity NPD5211 Phase 2
0.5775 Remote Similarity NPD4767 Approved
0.5733 Remote Similarity NPD6372 Approved
0.5694 Remote Similarity NPD4768 Phase 4
0.5658 Remote Similarity NPD6373 Phase 4
0.5658 Remote Similarity NPD6909 Phase 4
0.56 Remote Similarity NPD6882 Phase 4
0.5584 Remote Similarity NPD6908 Approved
0.5526 Remote Similarity NPD6333 Approved
0.5526 Remote Similarity NPD6334 Phase 4
0.5493 Remote Similarity NPD5696 Phase 4
0.5362 Remote Similarity NPD5286 Phase 4
0.5294 Remote Similarity NPD6079 Phase 4
0.5231 Remote Similarity NPD4195 Phase 4
0.5217 Remote Similarity NPD4629 Phase 4
0.5211 Remote Similarity NPD4633 Phase 4
0.5132 Remote Similarity NPD5983 Phase 2
0.5067 Remote Similarity NPD6012 Phase 4
0.5063 Remote Similarity NPD6009 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data